Gluten-detection devices and telemedicine to help adults with celiac disease
Official title: Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
Funded at Columbia University Health Sciences · NIH-11370961 · Data updated 2026-11-12
This project looks at whether using portable gluten sensors and urine gluten tests together with telemedicine can help adults with celiac disease stick to a gluten-free diet and feel better.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 15, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $163,367 |
| NIH project number | 3U01DK136523-03S1 |
| Project ID | NIH-11370961 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults diagnosed with celiac disease who are willing to use home gluten-detection tools and participate in telehealth visits are ideal candidates.
✕Less likely to help
People without celiac disease, children, or adults who are already strictly adherent to a gluten-free diet with no ongoing symptoms may not receive direct benefit.
What this research studies
If you have celiac disease, this project would pair regular telehealth visits with dietitians and home gluten-detection tools you can use on food or in urine. Participants will be taught to use portable gluten sensors and urine gluten immunogenic peptide kits and will report results to their care team during virtual visits. The research team will track diet adherence, symptoms, blood tests, and quality of life over time to see if the tools help reduce accidental gluten exposure. Some visits or tests may require occasional in-person follow-up at the study center.
Why it matters
Potential benefit: If successful, this approach could help people with celiac disease reduce accidental gluten exposure, improve symptoms, and make diet management easier.
How similar studies have gone: Smaller studies have shown gluten sensors and urine gluten peptide tests can detect exposures and telemedicine can support dietary care, but large controlled trials showing clear patient benefit are still limited.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Lebwohl, Benjamin — Columbia University Health Sciences
- Study coordinator: Lebwohl, Benjamin
Related research
Other NIH-funded projects on the same topics.
-
Understanding how immune cells interact in celiac disease to guide healing
A study from the University of Chicago will follow people with celiac disease to understand how immune cells in the gut contribute to damage or healing when gluten is present or restricted.
-
NanoDiscs: a new way to calm the immune system in celiac disease
A new, protein-like particle called NanoDiscs is being developed to deliver safe targets to the immune system in people with celiac disease, with the goal of reducing reactions to gluten.
-
Tissue damage and healing in Celiac Disease
A broad study at the University of Chicago is exploring why some people with celiac disease keep having symptoms and tissue damage even when they try to follow a gluten-free diet.
-
Gluten-sensing tech to help manage celiac disease with telemedicine
A study tests new gluten-detection tools used with online care to help adults with celiac disease manage their condition.
-
Role of Transglutaminase 2 in Celiac Disease
A study from Stanford aims to understand how a specific enzyme, TG2, contributes to celiac disease and to test a potential gut-focused treatment that could one day help people avoid dietary controls.
-
Gluten-specific immune responses in a humanized mouse model of celiac disease
A study in a special mouse that carries human immune system pieces to understand how gluten triggers celiac disease and to test potential therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.